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lesions can be addressed by this technique thereby reducing the
cost, as a single stent is sufﬁcient and also, the amount of metal at
the bifurcation is reduced, thereby reducing the incidence of rest-
enosis. To conclude TAP is a safe, easy, and cost effective techni-
que that can be used to address most of the bifurcation lesions.
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Background: In the present era of percutaneous coronary inter-
vention (PCI) dual antiplatelet therapy plays a pivotal role. How-
ever there exists inter individual variability in response to
antiplatelet therapy. Thus, monitoring antiplatelet therapy
becomes vital and may identify poor responders who would ben-
eﬁt from the change in therapy.
Objectives: We sought to identify the efﬁcacy of thienopyridine
antiplatelet drugs in post PCI patients, by using AggreGuide A-100
Platelet Aggregometer, point of care device developed to monitor
platelet aggregation using laser scattering technique.
Methods: This prospective, single-center study, includes patients
who received thienopyridine antiplatelet drugs after PCI during
May 2014–January 2015. In these patients, platelet aggregation
inhibition was evaluated from the whole blood sample using
AggreGuide A-100 and expressed in terms of platelet activity index
– PAI. Patients were labelled as poor responders (high on treatment
platelet reactivity) if the PAI was more than 5. Genetic polymorph-
isms of ABCB1 gene were studied in Clopidogrel group.
Results: A total of 405 patients were enrolled in this study. Among
them 109 (26.9%) were female and 296 (83.1%) were males, 108
(26.7%) underwent primary PCI and 297 (83.7%) underwent elective
PCI. At the discretion of treating physician 221 (54.6%), 111 (27.4%),
and 73 (18%) patients received Clopidogrel, Prasugrel, and Tica-
grelor, respectively. It is found that therapy was ineffective
(PAI > 5) in 73 (16%) patients of which 52, 8, and 5 were in Clopido-
grel, Prasugrel, and Ticagrelor groups, respectively. Cumulatively,
there was high PAI in females and those who underwent primary
PCI. In the Clopidogrel group those with additional Cilostazol were
having low PAI ( p < 0.05). Bleeding complicationswere observed in
3, 9, and 3 patients of Clopidogrel, Prasugrel, and Ticagrelor groups,
respectively. Four patients in Clopidogrel group had reinfarction.
Antiplatelet therapy was optimised in those with high PAI.
Conclusion: It is found that there is high resistance to antiplatelet
drugs (especially Clopidogrel), and thus monitoring individual's
platelet reactivity and optimising therapy based on it, should
become anewstandard-of-care for patients on antiplatelet therapy.
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Background: Rapid risk stratiﬁcation of the patient with acute
chest pain is essential to select the best management. Although
culprit lesions in STEMI cluster in the proximal coronary arteries,
their relationship to bifurcations and curvatures, where blood ﬂow
is disturbed, is unknown.
Objective: We investigated the value of the ECG at ﬁrst medical
contact to determine location and size of the ischemic myocardial
area and thereby severity of risk. We also hypothesized that (a)
culprit lesions are mostly localized to areas with disturbed ﬂow,
e.g. distal to bifurcations and curvatures and (b) the distribution of
culprit lesions in the left coronary artery (LCA) and right coronary
artery (RCA) and resulting infarct size are related to the location of
bifurcations and curvatures.
Methods: In patients with ST elevation myocardial infarction
(STEMI), ECG ﬁndings were correlated with the coronary angio-
gram. Using ST-segment deviation patterns the location of the
coronary culprit lesion was predicted and also the size of the
myocardium at risk. By quantitative coronary angiography,
the distances from the vessel ostium, major bifurcations, and
major curvatures to the culprit lesion were measured in 104
patients.
Results: Correct coronary culprit artery identiﬁcation was possible
in 96% of the patients and this wasmost accurate in localization of
culprit lesion in the proximal part of the coronary arteries. Culprit
lesions were located within 20 mm of a bifurcation in 77% of
patients and closer to the bifurcation in the LCA compared with
the RCA (10.13  7.09 vs 18.49  17.16 mm, p = 0.01). Of RCA culprit
lesions, 53% were located within 30 mm of a major curvature.
Compared with those in the RCA, culprit lesions in the LCA were
located more proximally (19.28  10.27 vs 28.77  20.65 mm,
p < 0.01) and were associated with larger myocardial infarctions
as assessed by CK-MB (139.5  139.4 vs 89.2  93.9 unit/L, p = 0.03),
and lower ejection fractions (39.58  7.0% vs 45.16  8.75%,
p = 0.001).
Conclusions: Admission ECG gives adequate insight regarding the
infarct related artery and the location of the lesion in the culprit
vessel. In patients with STEMI, culprit lesions are frequently
located immediately distal to bifurcations and in proximity to
major curvatures where disturbed ﬂow is known to occur. This
supports the role of wall shear stress in the pathogenesis of STEMI
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Background: Uric acid is the end product of nucleotide metabo-
lism. Serum uric acid when elevated is diagnostic of gout
and is a stress marker in hypertension. The correlation of serum
uric acid with coronary artery disease has been evaluated
though in small number cohort. Present study aims to correlate
the serum uric acid with the severity of CAD and as a marker of
CAD.
Materials andmethods: A total of 470 patients consecutively have
been enrolled into the study. The patients with already a diag-
nosis of gout, on long term use of thiazides and those responsible
for elevated serum urate levels were excluded from the study.
The patients enrolled underwent coronary angiography after
informed and written consent. Based on the results of CAG the
patients were divided into two groups, CAD (n = 350) and control
group (n = 120). The severity of CAD was assessed by modiﬁed
Gensini score.
Results: Mean age of presentation in CAD group was 53.72
 10.38 yrs and in controls was 49.60  9.82 yrs ( p < 0.0001). Males
in total cohort were 331 (70.43%). Hypertensives 226 vs 82 ( p = 0.54),
diabetics (161 vs 30, p = 0.60), smokers (209 vs 48, p = 0.64),
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Alcoholics (155 vs 45, p = 0.47), and family h/o CAD (43 vs 14,
p = 0.13). All the risk factors of CADwere equally matched between
two groups thereby removing the confounding factors if any that
may lead to biased results. The serum uric acid levels in cases
were signiﬁcantly higher than in control group (7.12  2.04 vs 5.6
 1.02 mg/dl, p < 0.0001). The correlation of serum uric acid with
CAD was positive (r = 0.35, p < 0.0001). A cut off point of 7.4 mg/dl
has been made by ROC analysis for the presence or absence
of CAD with sensitivity of 44.5% and speciﬁcity of 98.8%.
The correlation of serum uric acid with severity of CAD was
weak. The factors which were found to be statistically signiﬁcant
with univariate analysis were analysed by logistical regression
for the independent predictors of CAD. Age, sex, diabetes, RDW
CV, and serum uric acid were found to be independent predic-
tors of CAD.
Conclusion: Serum uric acid can be used as a marker of CAD for its
presence or absence but not with severity of CAD.
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Background: Serum bilirubin is having protective effect, as an
antioxidant with capacity to remove reactive species of oxygen.
Studies have suggested that an increased bilirubin level promotes
protection against atherosclerosis. We have evaluated the level of
serum bilirubin in patients with coronary artery disease and its
correlation with severity of lesion as assessed by modiﬁed Gensini
score on angiography.
Methods: A total of 540 patients have been enrolled in the study.
Patients with diagnosis of acute coronary syndrome, stable
angina, history of typical angina, and Treadmill test positivewere
enrolled in the study. All patients were conﬁrmed to have normal
liver and renal function and were taken written consent for
coronary angiography. The severity of lesion on angiography
was assessed by modiﬁed Gensini score. Based on angiography
results, the patients have been divided into CAD and control
group.
Results: The number of patients in CAD group were 380 and in
control group were 160. Mean age of presentation in control group
was 53.60  10.47 yrs compared to controls 49.56  10.01 yrs
( p < 0.0001). Males were 75.26% in CAD group and 55.62% in con-
trols ( p value is 0.1). The serum bilirubin was signiﬁcantly lower in
cases than in controls (0.66  0.28 mg/dl vs 0.79  0.30 mg/dl,
p < 0.0001). There was a signiﬁcant difference between other para-
meters assessed, i.e. RDW CV (14.46  0.74 vs 13.72  0.85,
p < 0.0001), RDWSD (45.61  4.42 vs 44.41  5.68, p = 0.0086), serum
uric acid (7.10  2.06 mg/dl vs 5.96  1.96 mg/dl, p < 0.0001). Uni-
variate analysis have been done followed by multivariate logistic
regression analysis for assessing the independent risk factors for
CAD. Serum bilirubin, RDW CV, sex, age, and diabetes were found
to be independent predictors of CAD (Table2). Serum bilirubin
negatively correlated with severity of CAD (r = 0.2121,
p < 0.0001). The cut off value of serum bilirubin based on Receiver
Operating Characteristic curve (ROC) analysis was 0.7 mg/dl for
presence or absence of CADwith sensitivity of 60.3% and speciﬁcity
of 58.1%. There is no signiﬁcant decrease between low serum
bilirubin in smokers compared to non-smokers both in cases
and control groups.
Conclusion: Serum bilirubin is negatively correlated with presence
and severity of CAD.
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Introduction: Red cell distribution width (RDW) is a measure of the
variability in the size of circulating erythrocytes, commonly utilized
in thedifferentialdiagnosisofanemia. IncreasedRDWreported tobe
a marker associated with the presence and adverse outcomes of
various cardiovascular diseases. RDW relation with the severity of
CAD is limited by small sample size in previous studies.
Objectives: The aim of the present study is to prospectively eval-
uate the severity of coronary artery disease on angiography as
assessed by Gensini score with RDW in patients admitted to
Osmania General Hospital, Hyderabad.
Methods: A total of 576 consecutive patients who underwent
coronary angiography after diagnosis of ACS (STEMI/NSTEMI),
CSA or presence of angina like chest pain and/or positive treadmill
test were enrolled in the study. Patients were divided into two
groups based on the results of coronary angiography CAD group
(n = 438) and control group (n = 138). The clinical information of the
enrolled patients including the classical risk factors of CAD, RDW
CV, and RDW SD were analyzed to identify their relationship to
CAD. Severity of CAD was evaluated by Gensini score and its
relationship to RDW was also analyzed.
Results: The mean age of presentation in CAD group was 53.64
 10.36 yrs whereas in controls was 49.4  9.73 yrs ( p < 0.0001).
Male:female ratio in the overall study was 2.42:1. Patients with
angiographic CAD had signiﬁcantly elevated RDW CV levels com-
pared with the controls [(14.59  1.04)% vs (13.6  0.68)%,
p < 0.0001]. The RDW SD levels were also signiﬁcantly elevated
compared with the controls [(45.78  4.76) vs (40.77  3.01),
p < 0.0001]. A signiﬁcant positive correlation between RDW CV,
RDWSD, and Gensini score was noted (r = 0.32, p < 0.0001) (r = 0.43,
p < 0.0001), respectively. In multivariate logistic regression analy-
sis, RDW was demonstrated to be an independent predictor for
angiographic CAD (OR = 4.17, 95% CI 3.05–5.69, p < 0.0001). In recei-
ver operating characteristic curve (ROC) analysis, an RDW value of
14.3%was identiﬁed as an effective cut off point in diagnosing CAD
with a sensitivity of 58.9% and speciﬁcity of 84.8%. Among the
classical CAD risk factors analyzed in CAD group, those with
hypertension were n = 287, 65.5%, h/o smoking (n = 243, 55.47%),
diabetes (n = 189, 43.15%), alcohol intake (n = 189, 43.15%), and
family history noted in 61 (13.92%) patients.
Conclusions: RDW is an independent predictor of CAD and severity
of coronary stenosis, suggesting that it might be a readily available
marker for prediction and severity of CAD.
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Background: Delay between the onset of symptoms and hospital
presentation is a critical factor in determining the management
strategy and subsequent outcome.
i n d i a n h e a r t j o u r n a l 6 7 ( 2 0 1 5 ) s 1 7 – s 4 8S32
